Business

Malınka Walaliyadde, CEO and cofounder of AKASA, discusses the advancement and current views on artificial intelligence and tuning generative AI for use to improve the coding process in healthcare and revenue cycle management to support ROI.

The company's Synapsis AI platform automates complex data readings, which allows for more efficient and optimal clinical research.

The funding includes $4.5 billion for the firm's core VC funds, $1.5 billion for its Creation strategy and $2 billion for separately managed accounts.

The round was led by Andreessen Horowitz, which has announced two other significant digital health investments within the past two weeks.

Medical illustrator David Bolinsky, E.mersion Studios CEO and creative director, creates animations representing molecular and cellular biology, and says AI image generators’ hallucinations may affect scientific medical illustration.

The message-based platform allows patients to get answers to complex medical questions, receive second opinions, seek urgent care and obtain assistance with end-of-life decisions.

Jenn Kerfoot, chief strategy and growth officer at DUOS, discusses why only seven plans made five stars for Medicare Advantage Star Ratings, as opposed to 30 the previous year, and how plans can ensure a positive rating in the future.

The New York-based company will use the investment to grow its partnerships and coverage among payers and move into Medicare populations in 2025.

Renato Umeton, director of AI operations and data science at Dana-Farber Cancer Institute, discusses building a secure environment to test and deploy LLMs to ensure responsible use, continuous innovation and limited access to outside AI tools.  

The company helps FQHCs, STD and Ryan White clinics develop, operate and grow in-house pharmacy programs focused on HIV and Hepatitis C patient populations.